$1 Billion is the total value of ARMISTICE CAPITAL, LLC's 67 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OPGN | Exit | OPGEN INC | $0 | – | -464,195 | -100.0% | -0.02% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INCcall | $0 | – | -26,000 | -100.0% | -0.06% | – |
| AVIR | Exit | AVIRAGEN THERAPEUTICS INC | $0 | – | -1,378,463 | -100.0% | -0.11% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -132,000 | -100.0% | -0.29% | – |
| EGLTQ | Exit | EGALET CORP | $0 | – | -2,050,000 | -100.0% | -0.31% | – |
| TSN | Exit | TYSON FOODS INCcl a | $0 | – | -50,000 | -100.0% | -0.42% | – |
| PIR | Exit | PIER 1 IMPORTS INC | $0 | – | -840,000 | -100.0% | -0.42% | – |
| SFM | Exit | SPROUTS FMRS MKT INC | $0 | – | -236,000 | -100.0% | -0.52% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -1,020,000 | -100.0% | -0.54% | – |
| NTRI | Exit | NUTRI SYS INC NEW | $0 | – | -100,000 | -100.0% | -0.66% | – |
| BETR | Exit | AMPLIFY SNACK BRANDS | $0 | – | -816,000 | -100.0% | -0.68% | – |
| SEAS | Exit | SEAWORLD ENTMT INCcall | $0 | – | -500,000 | -100.0% | -0.76% | – |
| ETSY | Exit | ETSY INC | $0 | – | -400,000 | -100.0% | -0.80% | – |
| ZGNX | Exit | ZOGENIX INCput | $0 | – | -200,000 | -100.0% | -0.83% | – |
| TTSH | Exit | TILE SHOP HLDGS INC | $0 | – | -632,000 | -100.0% | -0.94% | – |
| FTDCQ | Exit | FTD COS INC | $0 | – | -624,000 | -100.0% | -0.96% | – |
| Exit | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $0 | – | -21,760,000 | -100.0% | -1.08% | – | |
| ANF | Exit | ABERCROMBIE & FITCH COcl a | $0 | – | -700,000 | -100.0% | -1.19% | – |
| PII | Exit | POLARIS INDS INC | $0 | – | -100,000 | -100.0% | -1.23% | – |
| COH | Exit | COACH INC | $0 | – | -260,000 | -100.0% | -1.23% | – |
| TPX | Exit | TEMPUR SEALY INTL INCcall | $0 | – | -200,000 | -100.0% | -1.52% | – |
| DKS | Exit | DICKS SPORTING GOODS INC | $0 | – | -500,000 | -100.0% | -1.59% | – |
| SHPG | Exit | SHIRE PLCcall | $0 | – | -100,000 | -100.0% | -1.80% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -750,000 | -100.0% | -1.87% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -146,000 | -100.0% | -2.01% | – |
| NOMD | Exit | NOMAD FOODS LTD | $0 | – | -1,488,000 | -100.0% | -2.55% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -50,000 | -100.0% | -2.63% | – |
| CPB | Exit | CAMPBELL SOUP COcall | $0 | – | -500,000 | -100.0% | -2.76% | – |
| DECK | Exit | DECKERS OUTDOOR CORPcall | $0 | – | -500,000 | -100.0% | -4.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.